|
Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy
RECRUITINGSponsored by University Hospital Tuebingen
Actively Recruiting
SponsorUniversity Hospital Tuebingen
Started2020-08-01
Est. completion2021-12-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04878666
Summary
Prospective assessment of Quality of Life in patients with locally recurrent breast cancer after close R0, R1 or R2 resection or local inoperability and hyperthermic radiotherapy.
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Histologically confirmed local recurrence of breast cancer after close resection (≤1mm Resection margin), R1 or R2 resection respectively inoperable recurrence of the chest wall * age ≥18 Jahre * ECOG PS 0-2 * Estimated life expectancy more than 2 years * Informed consent Exclusion Criteria: * Extensive distant metastases that have an estimated life expectancy of \<2a * Heart disease: severe heart failure (NHYA III / IV), coronary heart disease, state after Myocardial infarction within the last 6 months), AV block III ° * Cardiac pacemaker * Second malignancy (except cervical carcinomas in situ, local controlled basaliomas, superficial bladder carcinomas (Ta, Tis, T1) or other carcinomas that have lasted more than 5 years behind and have been treated curatively) * Pregnancy or breastfeeding * Implanted port on the side to be treated in the Hyperthermia field (located contralateral is not an exclusion criteria) * Subclavian vein thrombosis less than \<6 months behind * Other circumstances that preclude hyperthermia * Circumstances that conflict with regular follow-up care * Transplanted organs * Other implants of the ipsilateral chest wall
Conditions2
Breast CancerCancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity Hospital Tuebingen
Started2020-08-01
Est. completion2021-12-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04878666